ASX: DXS
Dexus.
Prime office towers at 65 cents in the dollar, paying a 6.4% yield, with earnings set to dip before they recover.
Price A$5.79 (+0.9% on 2 November). Market cap about A$6.2b. Our full BGS 20 analysis, in eleven parts.
Summary
The story in 60 seconds.
A top-tier office landlord priced 35% below its own asset values, with a lower earnings year ahead and a chart that has stopped falling. Tap any card to jump to the detail.
1 · Company overview
Australia’s office landlord.
A$51.4b
Property on the Dexus platform, its own and its funds’.
Dexus (ASX: DXS) is one of Australia’s largest real estate groups. It owns a A$15.3b listed portfolio, A$9.8b of it office and A$3.6b industrial, concentrated in Sydney, Melbourne, Brisbane and Perth CBDs, and it manages A$36.1b of funds for pension funds and other investors (reported facts, 30 June 2026). Its names include 1 Bligh Street in Sydney, 360 Collins Street in Melbourne, 240 St Georges Terrace in Perth and Waterfront Brisbane.
It earns money three ways: rent from its own buildings, fees from managing other people’s property (plus performance fees when funds beat their benchmarks), and profits from developing and selling assets. Rent is the base; fees and trading profits are the swing.
Competitors are the other large landlords and fund managers: GPT, Mirvac, Charter Hall, Stockland and Goodman on the ASX, plus unlisted pension-fund owners and offshore capital.
Why now
The September quarter update (28 October) reaffirmed FY27 guidance and kept the distribution at 37 cents. The shares have held a A$5.30 to A$5.42 floor three times since June and closed at A$5.79 today, above their 40-day average. Meanwhile, the debate on interest rates is moving: we think the RBA is at or near the end of this cycle, and REITs are among the first to move when that becomes clear.
What the market may be missing
At A$5.79 the market values Dexus’s buildings about 35% below the A$8.92 NTA its independent valuers signed off in June. Some of that is fair: office values may still fall, and Dexus sold a Parramatta tower 7.1% below book last quarter. But its office occupancy of 94.2% sits nine points above the market average of 85.1%, and its CBD towers are the buildings tenants are moving to, not leaving.
Competitive advantage
Rating: MODERATE. Confidence: MEDIUM (inference).
- Quality and location: office occupancy of 94.2% by income against a market average of 85.1% (reported fact, PCA July 2026 data).
- Scale and funds platform: A$36.1b of funds under management and about A$2.0b of third-party equity raised in FY26 (reported facts).
- Development pipeline: A$12.8b, including Atlassian Central and Waterfront Brisbane, plus the Boral partnership for up to 2.5 million sqm of potential industrial space (reported facts).
- Credit strength: A-/A3 ratings from S&P and Moody’s (reported fact).
- No pricing power in office: average incentives are still 23.8% of the rent, so landlords are paying tenants to sign (reported fact).
- Heavy office weighting, about 64% of the listed portfolio, in a sector where demand changed after the pandemic (reported fact, inference).
2 · Fundamentals and earnings quality
A flat year, held up by one-offs.
45.0c
FY26 AFFO per security, in line with FY25.
| Year to 30 June | FY26 | FY25 | Change and read |
|---|---|---|---|
| Revenue (market data) | A$0.71b | A$0.95b | -25%, smaller portfolio after sales 🚩 |
| AFFO (A$m) | 483.9 | In line, per Dexus | Flat |
| AFFO per security | 45.0c | In line, per Dexus | Flat |
| Statutory net profit (A$m) | 482.2 | 136.1 | +254%, mostly valuation gains |
| Distribution per security | 37.0c | 37.0c | Flat, payout 82.1% of AFFO |
| Trading profits, post tax (A$m) | 42.5 | 3.9 | +38.6, not recurring |
| Performance fees (A$m) | 37.4 | 40.8 | -8%, not recurring |
| NTA per security | A$8.92 | A$8.81 | +1.2% |
| Office occupancy by income | 95.7% | 92.3% | +3.4 pts |
| Industrial occupancy by income | 94.6% | 96.2% | -1.6 pts 🚩 |
| Maintenance and leasing capex (A$m) | 185.4 | Higher, not stated | Down |
| EBITDA, EPS, operating cash flow, ROE, ROIC | Not in our data. REITs report AFFO in place of EBITDA | ||
| Key metrics, September quarter | Office, 30 Sep | Office, 30 Jun | Industrial, 30 Sep | Industrial, 30 Jun |
|---|---|---|---|---|
| Occupancy by income | 94.2% 🚩 | 95.7% | 94.0% | 94.6% |
| Occupancy by area | 93.6% | 95.5% | 95.4% | 96.5% |
| Weighted lease expiry (by income) | 4.0 yrs | 4.1 yrs | 4.2 yrs | 4.3 yrs |
| Average incentives | 23.8% | 26.4% | 20.1% | 20.6% |
| Stabilised leasing, 3 months | 36,100 sqm, 66 deals | 90,100 sqm, 17 deals |
Reported by Dexus (FY26 results, 20 August 2026; September 2026 quarter update, 28 October 2026). Revenue comes from the market data chart supplied by BG Trading, which shows net profit of A$0.61b for FY26; we use the A$482.2m statutory figure from the results release. The FY25 NTA is derived from the reported 11 cent increase.
3 · Balance sheet
Geared, but not stretched.
Look-through gearing was 33.4% at 30 June, or 34.6% if half of the A$500m of subordinated notes is treated as debt (reported facts). Debt has a weighted average maturity of 4.2 years, and Dexus holds A-/A3 credit ratings. Net debt is not disclosed in our sources; from the gearing and the NTA we estimate look-through net debt of about A$4.8b (BG Trading estimate).
The pressure point is cost, not access. Hedging averaged 91% at 3.0% in FY26, well below today’s market rates, and net finance costs already rose A$12.6m. As hedges roll off, interest costs keep rising, which is part of the lower FY27 guidance. Committed development spending of about A$490m in FY27 is covered by liquidity and asset sales (A$2.5b divested since FY24, above the A$2b target).
Classification: ADEQUATE. Comfortable gearing, strong ratings and plenty of liquidity. We stop short of strong because gearing is the highest in the peer group and refinancing costs are rising.
4 · Growth and pipeline
Earnings step down before they step up.
-14%
FY27 AFFO guidance midpoint (38.5c) against FY26 (45.0c).
CONTRACTINGFY27 guidance is AFFO of 37.5 to 39.5 cents per security and a distribution of 37.0 cents, reaffirmed on 28 October (management guidance). The fall comes from three things: lower trading profits and performance fees, higher finance costs, and less rent after A$1.9b of FY26 asset sales. Growth classification: CONTRACTING in FY27.
The growth that remains is in the pipeline. The A$12.8b development book includes A$6.9b on Dexus’s own balance sheet (A$2.4b committed). Atlassian Central in Sydney completes in late 2026 and starts paying rent; Waterfront Brisbane is 71% leased but delayed to late 2029, at a 5% to 6% yield on cost. The industrial book is 8.1% under-rented, with re-leasing spreads of about 36% last quarter, and about 21% of industrial income is up for renewal by FY28 (reported facts).
There is no backlog in the usual sense. The office weighted lease expiry of 4.0 years is the closest measure of contracted income. Funds management raised about A$230m of new equity since 30 June. Boral land and the data centre platform are options, not revenue.
5 · Outlook
FY27 projection: a reset year.
38.5c
Our base-case FY27 AFFO per security, the guidance midpoint.
| FY27 | Bear | Base | Bull |
|---|---|---|---|
| AFFO per security | 36.5c | 38.5c | 39.5c |
| Distribution per security | 34.0c | 37.0c | 37.0c |
| Payout of AFFO | 93% | 96% | 94% |
| Key assumption | Trading profits miss, office occupancy slides, distribution trimmed | Guidance midpoint, Atlassian Central on time | Fees and trading profits at the top end, rates ease |
BG Trading estimates, medium confidence, built on management guidance (AFFO 37.5c to 39.5c, distribution 37.0c). Analyst consensus for the FY27 distribution is also 37.0c (FNArena, 30 October 2026). Guidance was reaffirmed after the first quarter, so we rate it ACHIEVABLE; the payout ratio of about 96% leaves little room for a miss.
Beyond FY27
From FY28, a full year of Atlassian Central rent, industrial rent reviews and a smaller drag from one-offs should return AFFO to low single-digit growth (BG Trading estimate, no guidance). The buyback, which management calls a key medium-term lever, would add to earnings per security if funded from asset sales near book value.
Macro and industry
Macro: NEUTRAL, turning SUPPORTIVE if the RBA pivots. REITs are priced off bond yields, so the end of the hiking cycle matters more to Dexus than any single lease. Industry: MATURE. Office demand has stabilised in prime CBD buildings while secondary space struggles. The single most important variable is the 10-year bond yield, which sets office valuations and Dexus’s cost of debt.
6 · Valuation
Office towers at 65 cents in the dollar.
0.65×
Price to NTA. The market values the portfolio 35% below book.
UNDERVALUED| Metric | Value | Working |
|---|---|---|
| Market cap | A$6.22b | About 1,075m securities × A$5.79 |
| Enterprise value | About A$11.0b | 6.22b + about 4.8b look-through net debt (BG Trading estimate) |
| Price / NTA | 0.65× | 5.79 / 8.92, a 35.1% discount |
| Price / FY26 AFFO | 12.9× | 5.79 / 0.450 |
| Price / FY27 AFFO (guidance midpoint) | 15.0× | 5.79 / 0.385 |
| FY27 AFFO yield | 6.6% | 38.5c / 579c |
| Distribution yield | 6.4% | 37.0c / 579c. Franking not disclosed in our sources |
| P/E, FY26 statutory | 12.9× | 6,224 / 482.2. Not meaningful: driven by revaluations |
| EV / EBITDA, EV / revenue, PEG | Not used | EBITDA not reported for REITs; earnings falling |
| Analyst consensus | A$6.35 | FNArena, 30 Oct 2026; +9.7% from A$5.79. Broker views range from Underweight to Outperform |
Securities on issue derived from the A$397.4m FY26 distribution at 37.0c (BG Trading estimate, consistent with InvestSMART’s A$6.2b market cap). Net debt is estimated from 33.4% gearing on the A$8.92 NTA.
Classification: UNDERVALUED on assets, FAIR on earnings. At 0.65 times NTA the market is pricing roughly a further 35% fall in property values, or permanently lower office demand. At 15 times FY27 AFFO and a 6.4% yield, it prices in no earnings growth.
The peer comparison is in section 8.
7 · Catalysts and risk
Two dates that matter.
30 Nov
APAC appeal hearing (to 2 December), then half-year results in February.
Catalysts
| When | Catalyst | Impact | Status |
|---|---|---|---|
| 0 to 3 mo | Atlassian Central completion, late 2026 | Moderate | On schedule |
| 0 to 3 mo | APAC appeal hearing, 30 Nov to 2 Dec 2026, which decides the path for the infrastructure funds review | Moderate | Scheduled |
| 0 to 3 mo | 101 George Street, Parramatta, settlement | Low | Due November |
| 0 to 6 mo | Buyback restart | Moderate | Flagged, no size given |
| 0 to 6 mo | RBA decisions and bond yields | High | Speculative |
| 3 to 6 mo | Half-year results and distribution, February 2027 | High | Confirmed event |
| 3 to 6 mo | Infrastructure funds review outcome (A$7.3b of third-party funds, about A$35m of fees) | Moderate | Under way |
| 12 to 24 mo | Australian Data Centres lease talks for a hyperscale campus in Queensland | Moderate | Speculative, subject to approvals |
| 12 to 24 mo | Boral land rezoning and first industrial developments | Moderate | Speculative |
Risk
| Category | Risk | Probability | Impact |
|---|---|---|---|
| Valuation | Office values fall again and NTA is cut | Moderate | High |
| Fundamental | AFFO misses guidance with the payout near 96% | Moderate | High |
| Macro | Rates stay higher for longer | Moderate | High |
| Financial | Higher interest costs as cheap hedges roll off | High | Moderate |
| Industry | Office occupancy keeps slipping (down 1.5 points last quarter) | Moderate | Moderate |
| Execution | Development delays (Waterfront Brisbane already pushed to 2029) | Moderate | Moderate |
| Technical | A seven-year downtrend is still intact | High | Moderate |
| Governance | APAC litigation and the healthcare fund redemption queue | Moderate | Low |
| Dilution | An equity raise; unlikely with a buyback flagged | Low | Moderate |
8 · Peers comparison
Cheapest on assets. Not on earnings.
| Latest year | Dexus | GPT | Mirvac | Stockland | Charter Hall | Goodman |
|---|---|---|---|---|---|---|
| Business | Office-led REIT and fund manager | Diversified REIT | Diversified REIT and developer | Residential, communities, logistics | Fund manager | Industrial and data centres |
| Year end | 30 Jun 2026 | 31 Dec (1H to Jun 2026) | 30 Jun 2026 | 30 Jun 2026 | 30 Jun 2026 | 30 Jun 2026 |
| Price (date) | A$5.79 (2 Nov) | A$4.76 (23 Oct) | A$1.865 (30 Oct) | A$4.24 (15 Oct) | A$20.02 (26 Oct) | A$27.00 (30 Oct) |
| Market cap | A$6.2b | A$9.1b | A$7.3b | A$10.2b | A$9.5b | A$55.6b |
| Operating earnings per security (latest FY) | 45.0c AFFO | 35.4c FFO (2026 guidance) | 12.9c | 36.9c FFO | 103.2c | 129.9c |
| Next-year guidance, growth | 37.5c to 39.5c, -14% 🚩 | About +5% (1H26) | 13.2c to 13.4c, +2% to 4% | 38.0c to 39.0c, +3% to 6% | About 114c, +10.5% | +9% |
| Statutory net profit (A$m) | 482 (FY25: 136) | 400 (1H26) | 677 (FY25: 68) | 994 (+20%) | 428 (FY25: 328) | 2,779 (+67%) |
| Price / forward earnings | 15.0× | 13.4× | 14.0× | 11.0× | 17.6× | 19.1× |
| NTA per security | A$8.92 | A$5.61 | A$2.33 | A$4.39 | A$5.95 | A$11.79 |
| Price / NTA | 0.65× | 0.85× | 0.80× | 0.97× | 3.36× | 2.29× |
| Distribution yield (next year) | 6.4% | 5.1% | 5.3% | 5.9% | 2.7% | 1.1% |
| Gearing | 33.4% 🚩 | 31.5% | 24.1% | 22.7% | 14.2% | 6.5% (19.5% look-through) |
| Analyst target, upside | A$6.35, +9.7% | A$5.43, +14.1% | A$2.03, +8.7% | A$5.03, +18.6% | A$23.35, +16.6% | A$33.87, +25.4% |
Reported facts from each company’s August 2026 results; guidance is management guidance; targets are analyst consensus (FNArena, 26 to 30 October 2026, for Dexus, Mirvac, Charter Hall and Goodman; S&P Global via StockAnalysis, 30 September 2026, for GPT and Stockland). Market caps, multiples and upside are BG Trading estimates: securities derived from reported earnings divided by earnings per security. GPT’s forward multiple uses its calendar 2026 guidance, so the period differs. We compare on price to NTA and price to operating earnings because REITs do not report EBITDA and look-through net debt is not disclosed on a like basis, so EV multiples would not be comparable. Prices span 15 October to 2 November.
Ranking: Dexus is the cheapest on assets and the highest yielder, but it has the weakest earnings outlook (the only one going backwards) and the highest gearing. Charter Hall and Goodman trade well above NTA because they are mainly fund managers and developers, so price to NTA does not compare. The single most important difference is direction: every peer guides to growth in FY27, Dexus guides to a 14% fall.
Is (ASX: DXS) Dexus, undervalued or overvalued in comparison to its peers?
FAIRLY VALUED
- A 24% discount to GPT on price to NTA (1 – 0.65 / 0.85), 19% to Mirvac and 33% to Stockland, the three closest asset owners.
- But on FY27 earnings Dexus is 12% dearer than GPT (15.0 / 13.4 – 1), 7% dearer than Mirvac and 36% dearer than Stockland, because its earnings are falling.
- The highest yield in the group, 6.4%, about 1.1 points above GPT and Mirvac.
- The highest gearing (33.4%) and the most office exposure, so part of the asset discount is earned.
- Analyst upside of 9.7% is among the lowest in the group, with brokers split from Underweight to Outperform.
Against peers, the discount on assets and the premium on earnings roughly cancel: fairly valued. In absolute terms it is undervalued on assets (section 6), which matters if office values have bottomed.
9 · Technical analysis (BG Trading view)
The floor held three times.
3 tests
Of the A$5.30 to A$5.42 base since June, in June, July and late September. All held.
- Long-term trend: down since the 2019 high near A$13.90, under a falling trendline now near A$6.65 to A$6.70. The 250-day average (A$6.18) and the long-term weekly average (A$7.61) are both falling.
- Medium term: turning. Price is back above the 40-day average (A$5.62), which has flattened.
- Short term: up, above the 9-day average (A$5.72), with higher lows since late September.
- BGS 20 level: 6.3% below the 250-day average ((6.178 – 5.79) / 6.178), just under the Technically Fair band and above the Discount band. A technical measure, not a fundamental value.
- Support: the A$5.30 to A$5.42 base, tested in June, July and late September and held each time. Strong. Then the 40-day average near A$5.62.
- Resistance: the 250-day average near A$6.18, the A$6.40 to A$6.54 band (the 2023 to 2025 floor that broke in February), the falling trendline near A$6.70, then the December 2025 range above A$6.80.
- RSI: 60.5% on the daily and rising along a line of higher lows since February. Weekly RSI is 52% and has made higher lows since 2025 while price made lower lows: a bullish divergence.
- Volume: about average, around 3.1m a day. No accumulation surge yet. The one-off spike in September looks like index rebalancing (inference). A break above resistance needs volume to confirm it.
- Formation: a base after a long decline, a possible triple bottom. It is not confirmed until price clears the 250-day average and the band above it.
Probability view
Qualitative judgment calls from the chart, not statistical forecasts.
BGS 20 VIEW: Qualifies With Conditions
Positioning: This area is only available for VIP Members, click here to Subscribe.
10 · Our view
BGS 20 Score.
61
Out of 100. Business Quality 49. Setup Quality 62.
WAITA good company, a good stock and a good entry are three different questions. Here the buildings are good, the stock is cheap on assets, and the entry needs patience.
| Category | Score | Weight | Weighted |
|---|---|---|---|
| Fundamentals | 55 | 15% | 8.25 |
| Growth | 30 | 10% | 3.00 |
| Balance sheet | 60 | 10% | 6.00 |
| Valuation | 72 | 20% | 14.40 |
| Technical | 55 | 10% | 5.50 |
| Catalysts | 60 | 10% | 6.00 |
| Industry and macro | 50 | 10% | 5.00 |
| Risk / reward | 55 | 15% | 8.25 |
| Reversal Watch (three holds of support, weekly RSI divergence) | +5 | ||
| Total | 56.40 + 5 = 61 |
The biggest factor raising the score is valuation: a 35% discount to NTA and a 6.4% yield. The biggest factor lowering it is growth: AFFO is guided 14% lower in FY27. Business Quality and Setup Quality differ by 13 points.
Why WAIT and not SPECULATIVE BUY: at today’s price, the setup does not yet meet our risk limits. The score qualifies; the entry does not. A better entry, or a confirmed break above resistance, would change the rating.
Fair value
BG Trading estimates. Probability-weighted value about A$6.33. Base vs price = (6.40 – 5.79) / 5.79 = +10.5%. Probabilities are qualitative judgments.
Rating
| Company | Dexus (ASX: DXS) |
| Price / market cap | A$5.79 / about A$6.2b |
| BGS 20 level | 6.3% below the 250-day average, just under Technically Fair |
| Long-term fair value | A$4.90 to A$7.60, base A$6.40 |
| Upside to fair value | +10.5% to base, +9.3% to the probability-weighted value |
| Bull / bear probability | 25% / 25% |
| Valuation | Undervalued on assets, fairly valued against peers |
| Technical position | Base at support inside a long downtrend, Reversal Watch |
| Fundamental and growth trend | Flat FY26, contracting FY27 |
| Balance sheet / earnings quality | Adequate / moderate |
| Macro | Neutral, turning supportive if rates fall |
| Risk level | Moderate |
| Suitability | Moderate-risk and income investors. Medium-term position or swing trade |
Buy at the current price? Sign up for VIP membership to see this part.
- Reason to own: prime office and industrial property at 65 cents in the dollar, paying 6.4% while you wait for rates to turn.
- Reason not to own: earnings fall 14% this year, gearing is the highest in the peer group, and office values may not have bottomed.
- What breaks the thesis: a close below the June to September base, an NTA cut at the half-year, or a distribution cut (exact levels in the VIP area).
- Most important catalyst: the half-year result in February: AFFO run rate, valuations and the buyback.
- Driven by: interest rates and valuation first, then technicals.
- Asymmetric risk/reward: assessed in the VIP area.
- Discounted or undervalued: undervalued on assets, mildly discounted technically.
- Trade or investment: a medium-term position for income investors, a trade for everyone else until the downtrend breaks.
One more thing
Momentum turned before the price did.
REVERSAL WATCHSince 2025 the price has made lower lows, but weekly RSI has made higher ones, and the base has now held three times. That is how long downtrends often end, though it is not a confirmed reversal until the 250-day average gives way.
11 · VIP area
SHOULD I BUY (ASX: DXS) NOW?
ENTRY DETAILS, TRADING CONSIDERATIONS, TARGETS, SHAREHOLDER STATISTICS, HOLDING TREND (VIP AREA)
VIP Members only. Our entry price, targets, stop loss and shareholder statistics are for VIP Members.
Sources. Dexus 2026 annual results release and presentation (20 August 2026); Dexus September 2026 quarter update (28 October 2026); Dexus FY26 earnings call highlights (GuruFocus, August 2026); substantial holder register (InvestSMART, 2 November 2026) and Allan Gray change of substantial holding (FilingReader, 4 August 2026); FNArena consensus (Dexus, Mirvac, Charter Hall and Goodman, 26 to 30 October 2026); StockAnalysis and S&P Global consensus (GPT and Stockland, 30 September to 23 October 2026); GPT 2026 interim results (17 August 2026); Mirvac FY26 results (19 August 2026); Stockland FY26 results (19 August 2026); Goodman FY26 results (20 August 2026); Charter Hall FY26 results (21 August 2026), via StockWireX and FilingReader summaries of the ASX releases. Revenue history from the market data chart supplied by BG Trading. Photos and map: Dexus. Price from the BG Trading chart on 2 November 2026.
Disclaimer. The information contained in this report is provided by BG Trading Australia (ACN 161943228, License 4901880) for general informational purposes only and does not constitute personal financial product advice. It has been prepared without taking into account your objectives, financial situation, needs, or risk tolerance, and should not be relied upon as a substitute for independent professional advice tailored to your circumstances. Nothing in this report constitutes an offer, solicitation, or recommendation to buy, sell, or hold any financial product.
All technical levels, targets, and commentary reflect a point-in-time interpretation of publicly available chart data and are inherently speculative; markets are volatile and unpredictable, and no methodology, including the BGS 20 framework, can guarantee any particular outcome. Past performance is not, and should not be treated as, an indicator of future performance. To the maximum extent permitted by law, BG Trading Australia, its directors, employees, and agents disclaim all liability, whether direct or indirect, for any loss or damage arising from reliance on this report, including any errors, omissions, or inaccuracies in the information provided, and any decision made or action taken on the basis of it. You acknowledge that trading and investing carry inherent risk, including the risk of loss of capital, and that you act on this information entirely at your own discretion and risk. BG Trading recommends you obtain independent, licensed financial and taxation advice before making any investment decision.
BG Trading Australia | ACN 161943228 | Licence 4901880 | www.bgtrading.com.au
